Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Woodward, Inc. · WWD · FY2025 Q3 · Calendar Q3 2025
Woodward’s Q3 results and higher FY2025 outlook support a constructive operating picture, led by aerospace demand and aftermarket growth. The A350 actuator program and Safran acquisition extend the opportunity set, while rising investment, working capital and unresolved margin questions temper the picture.
Research this report with FN2. Free to start; review your question before sending.
Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Compared with Q2, management reported another record quarter and raised FY2025 sales and EPS guidance. The quarter also brought an Airbus A350 spoiler-actuator win, a planned U.S. production facility and completion of the Safran North American actuation-business acquisition—developments that add growth potential but increase execution and investment demands.
Management raised FY2025 sales and EPS guidance; the transcript analysis reports the updated EPS range at $6.50–$6.75. The supplied analysis does not specify the revised sales range.
Follow WWD with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Oct 28, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Oct 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 30, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 4, 2026 |
| UBS | Buy | Buy | Maintain | Apr 30, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 4, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 3, 2025 |
| Alembic Global | Overweight | Neutral | Upgrade | Aug 20, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 4, 2025 |
| Credit Suisse | Outperform | Outperform | Maintain | May 2, 2023 |
| SunTrust Robinson Humphrey | Sell | Hold | Downgrade | Jul 15, 2020 |
| Barrington Research | Market Perform | Outperform | Downgrade | Nov 20, 2019 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 26, 2017 |
| Keybanc | Underweight | Upgrade | May 21, 2015 | |
| Drexel Hamilton | Hold | Buy | Downgrade | Nov 11, 2014 |
| CL King | Buy | Neutral | Upgrade | Apr 23, 2014 |
| Maxim Group | Buy | Hold | Upgrade | Apr 23, 2013 |
| DA Davidson | Buy | Buy | Maintain | Feb 7, 2013 |
Upside is calculated against the persisted current price $326.56. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Guggenheim | Michael Ciarmoli | $410 | $333.88 | +25.6% | Nov 20, 2026 |
| Jefferies | Sheila Kahyaoglu | $425 | $335.92 | +30.1% | Nov 19, 2026 |
| Jefferies | Analyst unavailable | $420 | $329.94 | +28.6% | Oct 2, 2026 |
| Guggenheim | Analyst unavailable | $404 | $324.67 | +23.7% | Sep 14, 2026 |
| Melius Research | Scott Mikus | $388 | $337.26 | +18.8% | Sep 14, 2026 |
| Truist Financial | Analyst unavailable | $420 | $363.57 | +28.6% | Aug 4, 2026 |
| RBC Capital | Analyst unavailable | $430 | $351.26 | +31.7% | Jul 30, 2026 |
| Truist Financial | Analyst unavailable | $415 | $367.9 | +27.1% | May 5, 2026 |
| Deutsche Bank | Scott Deuschle | $470 | $362.99 | +43.9% | May 1, 2026 |
| RBC Capital | Ken Herbert | $450 | $374.91 | +37.8% | Apr 16, 2026 |
| Jefferies | Analyst unavailable | $450 | $388.5 | +37.8% | Feb 8, 2026 |
| Goldman Sachs | Analyst unavailable | $408 | $371.17 | +24.9% | Feb 3, 2026 |
| Truist Financial | Analyst unavailable | $404 | $381.68 | +23.7% | Feb 3, 2026 |
| UBS | Analyst unavailable | $417 | $327.25 | +27.7% | Feb 3, 2026 |
| Goldman Sachs | Analyst unavailable | $362 | $333.06 | +10.9% | Jan 20, 2026 |
| Jefferies | Sheila Kahyaoglu | $375 | $331.09 | +14.8% | Jan 16, 2026 |
| UBS | Analyst unavailable | $378 | $335.55 | +15.8% | Jan 15, 2026 |
| Truist Financial | Analyst unavailable | $366 | $319.23 | +12.1% | Jan 9, 2026 |
| Deutsche Bank | Analyst unavailable | $400 | $314.92 | +22.5% | Dec 22, 2025 |
| UBS | Analyst unavailable | $345 | $303.82 | +5.6% | Dec 1, 2025 |
| Jefferies | Sheila Kahyaoglu | $350 | $300.03 | +7.2% | Dec 1, 2025 |
| Truist Financial | Michael Ciarmoli | $305 | $288.74 | -6.6% | Nov 25, 2025 |
| UBS | Gavin Parsons | $329 | $261.18 | +0.7% | Nov 25, 2025 |
| Wolfe Research | Analyst unavailable | $300 | $254.37 | -8.1% | Oct 3, 2025 |
| Truist Financial | Michael Ciarmoli | $267 | $234.95 | -18.2% | Jun 12, 2025 |
| Truist Financial | Michael Ciarmoli | $232 | $210.61 | -29.0% | May 23, 2025 |
| Wells Fargo | Matthew Akers | $175 | $170.67 | -46.4% | Apr 15, 2025 |
| Deutsche Bank | Scott Deuschle | $187 | $170.02 | -42.7% | Apr 14, 2025 |
| Wells Fargo | Matthew Akers | $205 | $184.5 | -37.2% | Feb 4, 2025 |
| Deutsche Bank | Scott Deuschle | $180 | $171.38 | -44.9% | Jan 2, 2025 |
| Truist Financial | Michael Ciarmoli | $187 | $157.23 | -42.7% | Aug 21, 2024 |
| Jefferies | Sheila Kahyaoglu | $190 | $151.73 | -41.8% | Jul 31, 2024 |
| Deutsche Bank | Scott Deuschle | $158 | $151.73 | -51.6% | Jul 30, 2024 |
| Deutsche Bank | Scott Deuschle | $210 | $184.56 | -35.7% | May 28, 2024 |
| Truist Financial | Michael Ciarmoli | $152 | $151.07 | -53.5% | Apr 30, 2024 |
| Deutsche Bank | Scott Deuschle | $200 | $151.07 | -38.8% | Apr 30, 2024 |
| Wells Fargo | Matthew Akers | $172 | $151.07 | -47.3% | Apr 30, 2024 |
| Alembic Global | Analyst unavailable | $127 | $104 | -61.1% | Feb 1, 2023 |
| Truist Financial | Michael Ciarmoli | $80 | $84.08 | -75.5% | Oct 12, 2022 |
| Wells Fargo | Analyst unavailable | $117 | $101.95 | -64.2% | May 3, 2022 |
Track every rating change on WWD the moment it posts. Free to start.
Start freeWoodward, Inc. (WWD) stands as a prominent global entity, specializing in the engineering, production, and maintenance of advanced control solutions for both the aerospace and industrial sectors. The company organizes its operations into two distinct divisions: Aerospace and Industrial. Within its Aerospace segment, Woodward delivers a comprehensive array of crucial components. This includes fuel pumps, metering units, various types of actuators, air and specialized valves, fuel nozzles, and thrust reverser actuation systems, primarily designed for turbine engines and nacelles. Additionally, it provides flight deck controls, servocontrols, motors, and sensors for aircraft applications. These sophisticated offerings are integral to a wide range of platforms, encompassing commercial and private airplanes and rotorcraft, military fixed-wing and rotary-wing aircraft, guided munitions, and diverse defense systems.…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FRO Frontline Plc | FY2026 Q3 · Calendar Q4 2026 | — | +2.2% | Frontline posts record Q3 profit as spot tanker rates surge |
| ZTO ZTO Express (Cayman) Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.9% | -0.7% | Volume and retail-parcel growth support profit gains, with guidance cautious |
| ESLT Elbit Systems Ltd. | FY2026 Q3 · Calendar Q4 2026 | +1.4% | +5.8% | Elbit’s record backlog supports raised 2027 growth outlook, with execution risks |
| ACM Aecom | FY2026 Q4 · Calendar Q4 2026 | — | +11.1% | AECOM closes FY2026 with record backlog and margin; FY2027 outlook maintained |
| ARMK Aramark | FY2026 Q4 · Calendar Q4 2026 | -6.0% | +2.7% | Aramark Posts Record FY2026, Targets 9–10% Organic Growth in FY2027 |
| TTEK Tetra Tech, Inc. | FY2026 Q4 · Calendar Q4 2026 | +4.6% | +4.8% | Tetra Tech’s FY2026 Backlog Growth Supports a Strong FY2027 Pipeline |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-19. For educational purposes only; not investment advice.